EZH2 and leukemia: While mice with combined Ezh2 and Runx1 loss of function mutations targeted to early lymphoid progenitors (DKO mice) failed to develop leukemia and showed dramatically reduced thymus cellularity, the numbers of ETPs in the thymus were selectively and markedly expanded.